PATH (UiPath, NYSE) pre-market $12.45 on 19 Mar 2026: PATH stock eyes earnings catalyst
UiPath (PATH) trades pre-market at $12.45 on 19 Mar 2026 after a recent quarterly beat and a mixed forward guide. PATH stock reacted to a stronger-than-expected Q4 with revenue of $481.11 million and EPS of $0.30, yet management tempered full-year revenue growth. The market is weighing improving margins and buybacks against slower FY27 guidance and adoption risks. We assess valuation, technicals, Meyka grading, and a 1-year model forecast to help frame the opportunity ahead of the 28 May 2026 earnings catalyst.
Quick take: PATH stock price drivers
UiPath (PATH) opened pre-market at $12.45 after investors digested a Q4 beat and guidance that slowed FY27 revenue growth. The stock’s intraday range is $11.73–$12.65 with volume at 31,749,890, near the 30-day average. Recent buybacks (about $1.0B completed plus a $500.0M authorization) supported the rally but the full‑year guide capped upside.
News flow pushed short-term trading; the Q4 beat (revenue $481.11M, EPS $0.30) improved credibility, while the slower growth outlook created rotation into peers. Watch institutional activity and the upcoming 28 May 2026 earnings date as the next price catalyst.
PATH stock fundamentals and valuation
UiPath reports a market cap near $6.66B, EPS $0.54 (TTM) and a P/E around 23.06, with price/sales approximately 4.14 and price/book 3.21. The company has strong gross margins (~83.25%) and free cash flow yield near 5.28%, which support a premium versus legacy software peers.
Receivables are long (DSO ~131.60 days), but the balance sheet is healthy with debt to equity at 0.03 and cash per share about $2.75. Valuation reflects AI-driven growth expectations but also the risk of slower adoption; that tradeoff explains mixed analyst price targets and the current consensus near $14.27.
PATH stock technicals and market sentiment
Technicals show momentum but room for pullback: RSI 56.78, MACD histogram 0.25, and Bollinger upper band $12.67. The 50-day average sits at $12.93 and the 200-day at $13.41, so PATH stock is trading slightly below medium-term trend lines. On‑balance volume and MFI (73.87) point to recent buying interest.
Sentiment is mixed after earnings: sell‑side ratings skew toward Hold (majority) with three Buys and one Sell in recent notes. Institutional accumulation reported in filings may blunt volatility, but short-term swings are likely until revenue visibility improves.
Meyka AI rates PATH with a score out of 100 and forecast
Meyka AI rates PATH with a score out of 100: 77.91 (B+) — BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. Grades are informational and not guarantees; we are not financial advisors.
Meyka AI’s forecast model projects a 1‑year target of $13.83 versus the current $12.45, implying an upside of 11.12%. Forecasts are model-based projections and not guarantees. The model blends trend, fundamentals, and momentum signals and highlights the earnings date (28 May 2026) as a pivotal reassessment point.
PATH stock risks, opportunities and upcoming catalysts
Opportunities: Ai‑driven agentic automation adoption, platform expansion with partners like Deloitte, margin improvement, and buybacks support PATH stock upside. UiPath’s AI automation model can expand enterprise ARR and deepen wallet share.
Risks: Management guided to slower FY27 revenue growth (~10% implied), customer retention and speed of AI adoption remain execution risks, and analyst price‑target cuts can weigh on sentiment. Key catalysts: the next earnings on 28 May 2026, buyback execution, and further partner deployment news. For more context, see MarketWatch and Business Insider coverage MarketWatch and Business Insider.
Final Thoughts
UiPath (PATH) trades pre-market at $12.45 on 19 Mar 2026 with a clear near-term narrative: strong Q4 execution and buybacks versus a tempered FY27 revenue guide. PATH stock shows reasonable fundamentals — P/E 23.06, free cash flow yield 5.28%, and a healthy cash buffer — but adoption and retention risks explain mixed analyst sentiment. Meyka AI’s model projects $13.83 in one year, implying an 11.12% upside from today’s price; forecasts are model-based and not guarantees. Investors should watch the 28 May 2026 earnings and buyback updates to judge whether the stock’s valuation and AI-driven growth story re-rate higher. Meyka AI is cited here as an AI-powered market analysis platform providing the grade and model output
FAQs
What drove PATH stock higher recently?
PATH stock rose after Q4 results beat expectations (revenue $481.11M, EPS $0.30) and a substantial buyback. The rally was tempered by slower FY27 revenue guidance and mixed analyst reactions.
How does UiPath trade on valuation metrics?
UiPath trades at a P/E near 23.06, price/sales 4.14, price/book 3.21, and a free cash flow yield about 5.28%, reflecting AI growth expectations versus legacy software multiples.
What is Meyka AI’s forecast for PATH stock?
Meyka AI’s forecast model projects $13.83 in one year versus the current $12.45, implying an upside of 11.12%. These projections are model-based and not guarantees.
What are key catalysts for PATH stock soon?
Key catalysts include the next earnings on 28 May 2026, further buyback execution, partner deployments, and evidence of faster enterprise adoption of agentic AI automations.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)